Carlo Barone Selected Research

Carlo Barone Research Topics

Disease

28	Neoplasms (Cancer) 04/2019 - 07/2002
27	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 07/2002
14	Neoplasm Metastasis (Metastasis) 03/2020 - 03/2007
9	Breast Neoplasms (Breast Cancer) 08/2021 - 09/2003
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2005
8	Carcinoma (Carcinomatosis) 01/2017 - 08/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 02/2016
5	Fatigue 01/2019 - 06/2008
4	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 11/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2018 - 06/2008
4	Neutropenia 01/2017 - 08/2002
4	Disease Progression 01/2017 - 05/2010
3	Melanoma (Melanoma, Malignant) 12/2017 - 06/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2014 - 06/2008
3	Adenocarcinoma 05/2011 - 03/2006
3	Colonic Neoplasms (Colon Cancer) 07/2009 - 08/2002
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 02/2017
2	Hypertension (High Blood Pressure) 01/2019 - 01/2013
2	Diarrhea 01/2019 - 12/2013
2	Residual Neoplasm 09/2017 - 10/2015
2	Asthenia 06/2008 - 01/2007
2	Anaplastic Thyroid Carcinoma 01/2007 - 10/2005
1	Chemical and Drug Induced Liver Injury 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Hypophosphatemia 01/2019
1	Malignant Mesothelioma 01/2019
1	Sarcopenia 04/2018
1	Transitional Cell Carcinoma 02/2018
1	Uveal melanoma 12/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2017
1	Cachexia 10/2017
1	Anorexia 10/2017
1	Malnutrition (Nutritional Deficiencies) 10/2017
1	Hyperammonemia 04/2017
1	Confusion (Bewilderment) 04/2017
1	Brain Diseases (Brain Disorder) 04/2017

Drug/Important Bio-Agent (IBA)

8	Irinotecan (Camptosar)FDA LinkGeneric 07/2019 - 11/2003
6	Pharmaceutical PreparationsIBA 07/2019 - 02/2006
6	Cetuximab (Erbitux)FDA Link 01/2019 - 03/2006
6	ErbB Receptors (EGF Receptor)IBA 01/2019 - 08/2007
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 03/2006
6	Hormones (Hormone)IBA 01/2017 - 01/2007
6	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 08/2002
6	Leucovorin (Folinic Acid)FDA Link 12/2013 - 08/2002
6	Nevirapine (Viramune)FDA Link 05/2009 - 05/2003
5	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2002
5	regorafenibIBA 01/2019 - 01/2013
5	Cisplatin (Platino)FDA LinkGeneric 12/2017 - 04/2007
5	Reverse Transcriptase InhibitorsIBA 05/2009 - 10/2005
4	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 03/2010
4	Capecitabine (Xeloda)FDA Link 07/2019 - 02/2006
4	Monoclonal AntibodiesIBA 01/2019 - 08/2002
4	Tyrosine Kinase InhibitorsIBA 07/2016 - 11/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2017
3	Gemcitabine FDA Link 08/2018 - 06/2008
3	Sunitinib (Sutent)FDA Link 08/2013 - 03/2010
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2009 - 06/2005
3	efavirenz (Sustiva)FDA Link 06/2008 - 06/2005
2	Biomarkers (Surrogate Marker)IBA 08/2021 - 08/2015
2	tepotinibIBA 08/2021 - 01/2021
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 02/2017
2	Cytotoxins (Cytolysins)IBA 02/2018 - 05/2005
2	PlatinumIBA 01/2017 - 09/2009
2	AntibodiesIBA 04/2014 - 03/2011
2	Axitinib (AG 013736)IBA 12/2013 - 06/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013 - 06/2008
2	Epidermal Growth Factor (EGF)IBA 12/2011 - 05/2009
2	Docetaxel (Taxotere)FDA Link 05/2009 - 01/2007
2	Biological ProductsIBA 07/2008 - 10/2005
2	Filgrastim (Neupogen)FDA Link 04/2007 - 10/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2005 - 09/2003
2	lonidamineIBA 10/2005 - 09/2003
2	Epirubicin (Ellence)FDA LinkGeneric 10/2005 - 09/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2005 - 09/2003
1	MicroRNAs (MicroRNA)IBA 08/2021
1	trifluridine tipiracil drug combinationIBA 05/2021
1	atezolizumabIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	EnzymesIBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 08/2018
1	Albumin-Bound Paclitaxel FDA Link 08/2018
1	AlbuminsIBA 08/2018
1	Indicators and Reagents (Reagents)IBA 04/2018
1	Gefitinib (Iressa)FDA Link 04/2018
1	vinflunineIBA 02/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 12/2017
1	Dacarbazine (DIC)FDA LinkGeneric 12/2017
1	ORALIT (ORS)IBA 09/2017
1	AmmoniaIBA 04/2017
1	Interleukin-8 (Interleukin 8)IBA 03/2017

Therapy/Procedure

32	Therapeutics 05/2021 - 05/2005
29	Drug Therapy (Chemotherapy) 01/2022 - 08/2002
5	Neoadjuvant Therapy 08/2021 - 03/2005
3	Adjuvant Chemotherapy 07/2020 - 01/2008
2	Immunotherapy 12/2017 - 12/2016
1	Salvage Therapy 01/2019
1	Cystectomy 11/2017